Alpha Family Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$467K Hold
16,620
0.23% 77
2025
Q4
$414K Hold
16,620
0.19% 94
2025
Q3
$423K Hold
16,620
0.2% 91
2025
Q2
$403K Buy
+16,620
New +$388K 0.2% 95
2024
Q4
Sell
-16,670
Closed -$482K 169
2024
Q3
$482K Hold
16,670
0.27% 64
2024
Q2
$466K Buy
+16,670
New +$459K 0.27% 62
2024
Q1
Sell
-17,775
Closed -$512K 164
2023
Q4
$512K Buy
+17,775
New +$537K 0.35% 54
2023
Q3
Sell
-14,450
Closed -$530K 139
2023
Q2
$530K Buy
14,450
+2,305
+19% +$89.7K 0.37% 45
2023
Q1
$496K Sell
12,145
-1,205
-9% -$52K 0.39% 49
2022
Q4
$684K Buy
+13,350
New +$640K 0.62% 29
2022
Q3
Sell
-6,550
Closed -$343K 57
2022
Q2
$343K Buy
+6,550
New +$334K 0.22% 31

Other funds holding PFE

Alpha Family Trust's PFE Position: Q1 2026 in Review

Alpha Family Trust held its Pfizer (PFE) position steady in Q1 2026 at 16,620 shares worth $467K. The position accounts for 0.23% of the portfolio, ranked #77.

Alpha Family Trust first reported a position in PFE in Q2 2022 and has held it in 11 quarters since. The position peaked at $684K in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Alpha Family Trust held 16,620 shares of Pfizer worth $467K as of Q1 2026.
  • Alpha Family Trust left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.23% of Alpha Family Trust's portfolio in Q1 2026, its #77 holding.
  • Alpha Family Trust first reported a position in Pfizer in Q2 2022 and has held it in 11 quarters since.
  • Alpha Family Trust's Pfizer position peaked at $684K in Q4 2022.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Alpha Family Trust's 13F filing for Q1 2026, filed 13 May 2026.